1. Home
  2. FIGR vs TVTX Comparison

FIGR vs TVTX Comparison

Compare FIGR & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Figure Technology Solutions Inc.

FIGR

Figure Technology Solutions Inc.

HOLD

Current Price

$31.34

Market Cap

6.1B

Sector

Finance

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$62.34

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIGR
TVTX
Founded
2018
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
5.3B
IPO Year
2025
2013

Fundamental Metrics

Financial Performance
Metric
FIGR
TVTX
Price
$31.34
$62.34
Analyst Decision
Buy
Strong Buy
Analyst Count
9
13
Target Price
$53.22
$40.62
AVG Volume (30 Days)
3.4M
1.6M
Earning Date
05-11-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
92.89
EPS
0.18
N/A
Revenue
$506,865,000.00
N/A
Revenue This Year
$69.23
$44.76
Revenue Next Year
$24.25
$35.51
P/E Ratio
$177.11
N/A
Revenue Growth
48.69
N/A
52 Week Low
$24.11
$17.05
52 Week High
$78.00
$66.24

Technical Indicators

Market Signals
Indicator
FIGR
TVTX
Relative Strength Index (RSI) 57.19 62.67
Support Level $30.68 $53.76
Resistance Level $34.54 $66.24
Average True Range (ATR) 2.04 2.59
MACD 0.55 0.27
Stochastic Oscillator 73.99 67.32

Price Performance

Historical Comparison
FIGR
TVTX

About FIGR Figure Technology Solutions Inc.

Figure Technology Solutions Inc is building the future of capital markets with blockchain technology. proprietary technology powers next-generation lending, trading, and investing activities in areas such as consumer credit and digital assets. Its use of the blockchain ledger allows them to serve their end customers, improve speed and efficiency, and enhance standardization and liquidity. The Company operates as a single operating and reportable segment. The company's geographical operations is within the USA, with the majority of revenue from California.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: